SPOTLIGHT -
Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.
APPLE Study Analysis Provides New Insight into Heterogeneity in Pediatric Systemic Lupus Erythematosus
Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research
Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients
Introducing the Relatable Rheumatology: From Stories to Studies Podcast
Achieving Remission with Methotrexate or TNFi Linked to Lower CV Risk in Rheumatoid Arthritis
Report: For US Patients, Gout Burden Greatest Among Asian Americans